Tag Archives: antibiotics
Harvard study questions citizens’ preparedness for anthrax attack
A recent study by researchers at the Harvard School of Public Health found that 89 percent of Americans, in the event of a significant anthrax bioattack, would follow public health recommendations in obtaining antibiotics. Read More
Nanoviricides teams up with UC – Berkeley professor to test dengue virus drug candidates
A research and development agreement has been signed between NanoViricides, Inc., and the laboratory of Dr. Eva Harris at the University of California – Berkeley to evaluate the effectiveness of Nanoviricides drug candidates against dengue viruses. Read More
Scott Habig joins Human Genome Sciences
Scott Habig has joined Human Genome Sciences, Inc., as vice president of sales. Read More
Study published by Soligenix on characteristics of ricin A chain
Soligenix, Inc., has announced the publication of an article that details the characteristics of several immunodominant regions of ricin A chain – the antigenic component of Rivax – in the January 2010 edition of Infection and Immunity. Read More
Positive results announced for Restanza in treatment of inhaled tularemia
Positive top-line results have been announced by Advanced Life Sciences Holdings, Inc., for its once-a-day, oral antibiotic Restanza to treat inhaled lethal doses of tularemia. Read More
University of Illinois to develop antibiotics against potential bioterrorism agents
Researchers at the University of Illinois at Chicago have received a $4 million federal grant to develop new antibiotics to treat anthrax, tularemia and plague, the university announced Nov. 10.
Read More
Scientists Announce Possible Treatment for Deadly Virus
A team of Australian and U.S. scientists believe they have found an antibody that could protect humans from the deadly Hendra virus, Australia’s Northern Miner reported yesterday. Read More
Emergent BioSolutions appoints Ronald Richard to board of directors
GAITHERSBURG, Md. Read More
Emergent BioSolutions establishes office in Germany
GAITHERSBURG, Md. Read More
FDA to discuss experimental drug’s effectiveness against anthrax
A Human Genome Sciences Inc. drug worked better than a placebo but similar to antibiotics for treating anthrax exposure in animal studies, U.S. drug reviewers said in a summary released Oct. 23. Read More











